Veritas Pharma Inc
Indigenous Bloom Hemp Corp. focuses on the production of hemp products. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. The company is headquartered in Kelowna, Canada.
Market Cap & Net Worth: Veritas Pharma Inc (VRTHF)
Veritas Pharma Inc (PINK:VRTHF) has a market capitalization of $106.70K ($106.70K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41493 globally and #13505 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Veritas Pharma Inc's stock price $0.00 by its total outstanding shares 71136000 (71.14 Million).
Veritas Pharma Inc Market Cap History: 2016 to 2025
Veritas Pharma Inc's market capitalization history from 2016 to 2025. Data shows change from $163.26 Million to $106.70K (-57.57% CAGR).
Veritas Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Veritas Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VRTHF by Market Capitalization
Companies near Veritas Pharma Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Veritas Pharma Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Veritas Pharma Inc Historical Marketcap From 2016 to 2025
Between 2016 and today, Veritas Pharma Inc's market cap moved from $163.26 Million to $ 106.70K, with a yearly change of -57.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $106.70K | 0.00% |
| 2024 | $106.70K | 0.00% |
| 2023 | $106.70K | -90.00% |
| 2022 | $1.07 Million | -75.69% |
| 2021 | $4.39 Million | -46.25% |
| 2020 | $8.17 Million | +12.11% |
| 2019 | $7.28 Million | -86.35% |
| 2018 | $53.35 Million | -89.58% |
| 2017 | $511.82 Million | +213.51% |
| 2016 | $163.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Veritas Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $106.70K USD |
| MoneyControl | $106.70K USD |
| MarketWatch | $106.70K USD |
| marketcap.company | $106.70K USD |
| Reuters | $106.70K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.